These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 19601472)
41. False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells. Ali TZ; Epstein JI Am J Surg Pathol; 2008 Dec; 32(12):1890-5. PubMed ID: 18813120 [TBL] [Abstract][Full Text] [Related]
42. Cytokeratin (AE1/AE3) in addition to alpha-methylacyl coenzyme A racemase (P504S), 34-beta-E12, and p63 stains in evaluation of surgical specimens after hormonal therapy for prostatic adenocarcinoma. Raspollini MR Hum Pathol; 2008 Feb; 39(2):304-5; author reply 305-6. PubMed ID: 18206500 [No Abstract] [Full Text] [Related]
43. [Skin metastases in prostatic cancer. Immunohistologic indications of the primary tumor]. Schoel J; Smolle J; Kerl H Hautarzt; 1989 Jan; 40(1):34-6. PubMed ID: 2466019 [TBL] [Abstract][Full Text] [Related]
44. Ductal ("endometrioid") adenocarcinoma of the prostate. Colpaert C; Gentens P; Van Marck E Acta Urol Belg; 1998 Dec; 66(4):29-32. PubMed ID: 10083631 [TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining. Weinbreck N; Marie B; Bressenot A; Montagne K; Joud A; Baumann C; Klein O; Vignaud JM Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143 [TBL] [Abstract][Full Text] [Related]
46. Adenocarcinomas of the prostatic duct in necropsy material. Stamatiou K; Alevizos A; Mariolis A; Fanou D; Alevizou A; Michalodimitrakis E; Sofras F Can J Urol; 2007 Apr; 14(2):3502-6. PubMed ID: 17466156 [TBL] [Abstract][Full Text] [Related]
47. Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features. Seipel AH; Delahunt B; Samaratunga H; Egevad L Pathology; 2016 Aug; 48(5):398-405. PubMed ID: 27321992 [TBL] [Abstract][Full Text] [Related]
48. Radical prostatectomy for high-risk prostate cancer: biochemical outcome. Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167 [TBL] [Abstract][Full Text] [Related]
49. Calcifications in prostate and ejaculatory system: a study on 298 consecutive whole mount sections of prostate from radical prostatectomy or cystoprostatectomy specimens. Suh JH; Gardner JM; Kee KH; Shen S; Ayala AG; Ro JY Ann Diagn Pathol; 2008 Jun; 12(3):165-70. PubMed ID: 18486891 [TBL] [Abstract][Full Text] [Related]
51. Intravesical botryoid adenocarcinoma of the prostate: report of an unusual growth pattern of prostatic carcinoma simulating a urinary bladder tumor. Camilot D; Pizzolitto S; DeMaglio G; Falconieri G Ann Diagn Pathol; 2007 Dec; 11(6):413-6. PubMed ID: 18022125 [TBL] [Abstract][Full Text] [Related]
52. Prostatic stromal sarcoma in a young adult: a case report. Chang YS; Chuang CK; Ng KF; Liao SK Arch Androl; 2005; 51(6):419-24. PubMed ID: 16214726 [TBL] [Abstract][Full Text] [Related]
53. Secondary colonic adenocarcinoma of the prostate histologically mimicking prostatic ductal adenocarcinoma. Mai KT; Landry DC; Collins JP Tumori; 2002; 88(4):341-4. PubMed ID: 12400988 [TBL] [Abstract][Full Text] [Related]